42.33
0.57%
0.24
시간 외 거래:
42.33
전일 마감가:
$42.09
열려 있는:
$42.22
하루 거래량:
947.97K
Relative Volume:
0.84
시가총액:
$9.41B
수익:
$1.94B
순이익/손실:
$72.70M
주가수익비율:
29.19
EPS:
1.45
순현금흐름:
$405.21M
1주 성능:
+0.57%
1개월 성능:
+0.50%
6개월 성능:
-5.98%
1년 성능:
+1.73%
Qiagen Nv Stock (QGEN) Company Profile
QGEN을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
QGEN | 42.33 | 9.41B | 1.94B | 72.70M | 405.21M | 1.45 |
TMO | 516.10 | 196.16B | 42.37B | 6.14B | 7.78B | 15.26 |
DHR | 235.05 | 167.17B | 23.74B | 3.89B | 4.98B | 7.93 |
A | 132.06 | 37.94B | 6.50B | 1.41B | 1.42B | 3.82 |
IQV | 197.60 | 35.86B | 15.32B | 1.41B | 1.96B | 5.95 |
IDXX | 418.55 | 34.27B | 3.84B | 866.24M | 792.60M | 9.80 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-12-19 | 개시 | Wells Fargo | Equal Weight |
2023-12-13 | 개시 | Wolfe Research | Peer Perform |
2023-12-07 | 업그레이드 | Goldman | Neutral → Buy |
2023-09-12 | 개시 | Robert W. Baird | Outperform |
2023-05-23 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2022-10-18 | 개시 | Morgan Stanley | Equal-Weight |
2022-01-18 | 업그레이드 | DZ Bank | Hold → Buy |
2021-10-15 | 재개 | Cowen | Market Perform |
2021-10-14 | 개시 | Redburn | Buy |
2021-07-14 | 다운그레이드 | Kepler | Buy → Hold |
2021-06-03 | 개시 | Goldman | Neutral |
2020-10-06 | 재개 | BofA Securities | Buy |
2020-09-28 | 업그레이드 | Kepler | Hold → Buy |
2020-08-24 | 업그레이드 | Citigroup | Neutral → Buy |
2020-08-20 | 재개 | JP Morgan | Overweight |
2020-08-17 | 업그레이드 | Berenberg | Hold → Buy |
2020-08-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
2020-08-14 | 업그레이드 | Exane BNP Paribas | Neutral → Outperform |
2020-03-04 | 다운그레이드 | Berenberg | Buy → Hold |
2020-01-08 | 개시 | Wells Fargo | Equal Weight |
2020-01-07 | 개시 | Citigroup | Neutral |
2019-12-26 | 재개 | BofA/Merrill | Underperform |
2019-11-15 | 개시 | Stifel | Hold |
2019-11-14 | 업그레이드 | Evercore ISI | In-line → Outperform |
2019-11-14 | 업그레이드 | JP Morgan | Underweight → Overweight |
2019-11-14 | 업그레이드 | Kepler | Reduce → Hold |
2019-10-17 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
2019-10-09 | 다운그레이드 | Kepler | Hold → Reduce |
2019-10-08 | 다운그레이드 | Barclays | Overweight → Equal Weight |
2019-10-08 | 다운그레이드 | Deutsche Bank | Buy → Hold |
2019-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
모두보기
Qiagen Nv 주식(QGEN)의 최신 뉴스
Massachusetts Financial Services Co. MA Sells 79,145 Shares of Qiagen (NYSE:QGEN) - MarketBeat
Jennison Associates LLC Boosts Holdings in Qiagen (NYSE:QGEN) - MarketBeat
QIAGEN NV : Jefferies is Neutral - Marketscreener.com
Qiagen (NYSE:QGEN) Stake Lowered by Nuance Investments LLC - MarketBeat
QIAGEN Stock Flat Post Q3 Earnings & Revenue Beat, 2024 EPS View Up - MSN
Analysts Set Qiagen (NYSE:QGEN) Price Target at $50.88 - MarketBeat
Qiagen (NYSE:QGEN) Shares Bought by Natixis Advisors LLC - MarketBeat
180,729 Shares in Qiagen (NYSE:QGEN) Purchased by Impax Asset Management Group plc - MarketBeat
QGEN Collaborates With McGill University Centre: Stock to Gain? - Yahoo Finance
Victory Capital Management Inc. Has $117.33 Million Stock Position in Qiagen (NYSE:QGEN) - MarketBeat
What is William Blair's Estimate for Qiagen FY2024 Earnings? - MarketBeat
Crossmark Global Holdings Inc. Sells 12,133 Shares of Qiagen (NYSE:QGEN) - MarketBeat
Pharmahungary Group participates in ambitious EU EVEREST Project - European Biotechnology News
QIAGEN collaborates with McGill University to advance microbiome research - GlobeNewswire
QIAGEN Partners with McGill to Target $1.8B Microbiome Market in Major Research Deal | QGEN Stock News - StockTitan
Don't Overlook Qiagen (QGEN) International Revenue Trends While Assessing the Stock - Yahoo Finance
QIAGEN NV : UBS reiterates its Neutral rating - Marketscreener.com
Earnings call: QIAGEN tops Q3 expectations, raises 2024 EPS outlook - Investing.com India
Earnings call: QIAGEN tops Q3 expectations, raises 2024 EPS outlook By Investing.com - Investing.com Australia
Qiagen Non-GAAP EPS of $0.46 beats by $0.02, revenue of $459M beats by $2.09M - MSN
Wellington Management Group LLP's Strategic Acquisition of Qiage - GuruFocus.com
Why Qiagen (QGEN) is a Top Value Stock for the Long-Term - Yahoo Finance
Qiagen NV (QGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements - GuruFocus.com
Qiagen Reports Strong Q3 2024 Growth - TipRanks
Is There An Opportunity With Qiagen N.V.'s (NYSE:QGEN) 31% Undervaluation? - Yahoo Finance
QIAGEN NV : Deutsche Bank reaffirms its Buy rating - Marketscreener.com
Qiagen Q3 24 Earnings Conference Call At 9:30 AM ET - Nasdaq
QIAGEN : Markets hailed the Q3 beat + the profitability upgrade - Marketscreener.com
QIAGEN NV : Receives a Buy rating from Berenberg - Marketscreener.com
Qiagen (NYSE:QGEN) Shares Sold by Van ECK Associates Corp - MarketBeat
Qiagen N : QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full year 2024 adjusted EPS outlook - Marketscreener.com
QIAGEN NV : UBS reaffirms its Neutral rating - Marketscreener.com
Qiagen N.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Compared to Estimates, Qiagen (QGEN) Q3 Earnings: A Look at Key Metrics - Yahoo Finance
Qiagen (QGEN) Q3 Earnings and Revenues Top Estimates - Yahoo Finance
Diagnostics firm Qiagen reports rise in third-quarter revenue - Reuters
QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full-year 2024 adjusted EPS outlook - The Manila Times
QIAGEN Q3 Earnings Surge: Sales Hit $502M, Boosts 2024 EPS Outlook | QGEN Stock News - StockTitan
Qiagen NV (QGEN) Q3 2024: Everything You Need to Know Ahead of E - GuruFocus.com
FDA clears fourth Qiagen test in 2024 - BioWorld Online
Qiagen NV (QGEN) Q3 2024 Earnings Report Preview: What to Expect - GuruFocus.com
QGEN Stock Set to Gain From FDA's Clearance of QIAstat-Dx Mini Panel - Yahoo Finance
Qiagen (QGEN) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates - Yahoo Finance
QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics - GlobeNewswire
Qiagen Receives FDA Clearance Of Qiastat-Dx Meningitis/Encephalitis Panel To Support Emergency Diagnostics - XM
Forsta AP Fonden Sells 18,586 Shares of Qiagen (NYSE:QGEN) - MarketBeat
Qiagen (QGEN) Set to Announce Earnings on Wednesday - MarketBeat
Raymond James & Associates Trims Position in Qiagen (NYSE:QGEN) - MarketBeat
Global Exosome Market to Surge at a Tremendous CAGR of ~20% by 2030 | DelveInsight - GlobeNewswire Inc.
QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment - GlobeNewswire
Qiagen Nv (QGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):